Location History:
- Saint Romy les Chevreuse, FR (2013)
- Saint Remy les Chevreuse, FR (2021 - 2024)
Company Filing History:
2 out of 1,179 
1 out of 23 
Years Active: 2013-2024
Title: Servane Coste-Leconte: Innovator in Pharmaceutical Chemistry
Introduction
Servane Coste-Leconte is a notable inventor based in Saint Remy les Chevreuse, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on crystalline phases of benzimidazole compounds. With a total of 3 patents to her name, her research has implications for medical therapy.
Latest Patents
Coste-Leconte's latest patents focus on the crystalline phases of 5,6-dichloro-2-(isopropylamino)-(1 β-L-ribofuranosyl)-1H-benzimidazole, commonly known as Maribavir. These inventions relate to novel crystalline phases and pharmaceutical compositions that can be utilized in medical therapy. The detailed exploration of these compounds showcases her commitment to advancing pharmaceutical science.
Career Highlights
Throughout her career, Servane Coste-Leconte has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Takeda Pharmaceutical Company Limited and Viropharma Incorporated. Her experience in these organizations has allowed her to develop her expertise and contribute to significant advancements in drug development.
Collaborations
Coste-Leconte has collaborated with esteemed colleagues in her field, including Gerard Coquerel and Guillaume Levilain. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Servane Coste-Leconte is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in medical therapy. Her patents and collaborations reflect her dedication to innovation and the betterment of healthcare.